Clinical Trial Update: Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing autologous stem cell transplantation to conventional chemotherapy in high-risk Waldenström macroglobulinemia has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Waldenström Macroglobulinemia | Phase 4 | Status: COMPLETED